Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      • Home
      • Medical Dialogues...

      Articles By : Medical Dialogues Bureau

      Apollo Munich Health Insurance launches Roshini to empower women

      Apollo Munich Health Insurance launches Roshini to empower women

      Medical Dialogues Bureau15 Jun 2018 10:00 AM IST
      New Delhi: Apollo Munich Health Insurance has launched its flagship initiative 'Roshini' to empower women from economically and socially weaker...
      China to conduct training programmes for Indian pharma cos on regulatory system

      China to conduct training programmes for Indian pharma cos on regulatory system

      Medical Dialogues Bureau15 Jun 2018 9:45 AM IST
      New Delhi: China has agreed to conduct specific training programmes for domestic pharmaceutical companies to understand their regulatory system, which...
      Strides Shasun gets USFDA nod for Oseltamivir Phosphate capsules

      Strides Shasun gets USFDA nod for Oseltamivir Phosphate capsules

      Medical Dialogues Bureau14 Jun 2018 10:30 AM IST
      New Delhi: Drug firm Strides Shasun said its subsidiary Strides PharmaGlobal Pte has received final approval from the US Food and Drug Administration...
      Suven Life gets product patents from China, US

      Suven Life gets product patents from China, US

      Medical Dialogues Bureau14 Jun 2018 10:15 AM IST
      NEW DELHI: Suven Life Sciences today said it has been granted a product patent by China and the US each for a new chemical entity (NCE) for treatment...
      Fortis Healthcare extends deadline for submission of binding bids to June 28

      Fortis Healthcare extends deadline for submission of binding bids to June 28

      Medical Dialogues Bureau13 Jun 2018 10:36 AM IST
      New Delhi: Cash-strapped Fortis Healthcare, which is in the process of finding a buyer, has extended the deadline for submission of binding bids to...
      Orchid Pharma gets EUGMP certification for its Alathur facility

      Orchid Pharma gets EUGMP certification for its Alathur facility

      Medical Dialogues Bureau13 Jun 2018 10:00 AM IST
      New Delhi: Drug firm Orchid Pharma on Monday said it has received EU Good Manufacturing Practice certification after inspection of its Alathur...
      Alibaba injects pharmacy assets into healthcare unit in $1.4 billion deal

      Alibaba injects pharmacy assets into healthcare unit in $1.4 billion deal

      Medical Dialogues Bureau30 May 2018 12:12 PM IST
      SHANGHAI, - Chinese e-commerce giant Alibaba Group Holding Ltd will inject some of its online pharmacy business into a listed unit in a deal valued at...
      Ayushman Bharat a tectonic shift in Indian healthcare: PwC

      Ayushman Bharat a tectonic shift in Indian healthcare: PwC

      Medical Dialogues Bureau30 May 2018 12:12 PM IST
      New Delhi: Global consultancy firm PwC has said the Indian government's flagship programme 'Ayushman Bharat' will result in a tectonic shift in the...
      Fortis Healthcare starts fresh bidding process

      Fortis Healthcare starts fresh bidding process

      Medical Dialogues Bureau30 May 2018 12:08 PM IST
      Fortis Healthcare Ltd on Tuesday decided to initiate a fresh bidding process, after the board's previous choice of the investment offer in the bidding...
      Glenmark posts Q4 net profit at Rs 151 crore

      Glenmark posts Q4 net profit at Rs 151 crore

      Medical Dialogues Bureau30 May 2018 10:08 AM IST
      New Delhi: Glenmark Pharmaceuticals on Tuesday reported a consolidated net profit of Rs 151.62 crore for the fourth quarter ended March 2018.The...
      Hester Biosciences Q4 net up 27 percent

      Hester Biosciences Q4 net up 27 percent

      Medical Dialogues Bureau17 May 2018 9:15 AM IST
      New Delhi: Hester Biosciences reported 26.72 percent rise in standalone net profit to Rs 9.01 crore for the March quarter, 2017-18.It had posted the...
      USFDA completes inspection of Lupins Nagpur plant

      USFDA completes inspection of Lupin's Nagpur plant

      Medical Dialogues Bureau15 May 2018 11:01 AM IST
      New Delhi: Pharma major Lupin said the US health regulator has completed the inspection of its Nagpur facility without making any observations.In a...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok